Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has reported revenue of US$6.12 million for the six months to December 31 ...

Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has secured a further US$720,000 in non-dilutive funding after completing a key enrolment milestone in its ongoing US paediatric clinical study for ...

Lumos reaches enrolment milestone in a paediatric clinical study assessing use of its FebriDx point of care test, to differentiate ... Read More The post Lumos achieves first enrolment milestone in ...

The performance of the ASX life sciences sector during the reporting season is a precautionary tale about not trusting ...

Fresh tariff drama out of the US rattled markets on Monday, sending the ASX lower as investors rotated into gold ... Read ...

Emerging diagnostic technologies are key in combating antimicrobial resistance, presenting significant market opportunities. Six major pathogen areas are ripe for advancement, with over 30 companies ...

ASX 200 futures are pointing modestly higher this morning after gains on Wall Street, with gold and copper both firmer ...

(MENAFN- GlobeNewsWire - Nasdaq) Emerging diagnostic technologies are key in combating antimicrobial resistance, presenting significant market opportunities. Six major pathogen areas are ripe for ...

At 7am Sydney time on Monday, ASX futures were already wearing a black armband – down a chunky 0.7% and pointing to a sour start to the month. The Dow fell 0.36%, the S&P 500 dropped 0.43%, and the ...